|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Restricted Stock Units | (1) | 03/31/2016 | M | 1,666 | (3) | (3) | Common Stock | 1,666 | $ 0 | 1,667 | D | ||||
Restricted Stock Units | (1) | (4) | (4) | Common Stock | 3,000 | 3,000 | D | ||||||||
Stock Options (Right to Buy) | $ 108.49 | (4) | 08/07/2022 | Common Stock | 12,500 | 12,500 | D | ||||||||
Stock Options (Right to buy) | $ 108.49 | (5) | 08/07/2022 | Common Stock | 25,000 | 25,000 | D | ||||||||
Stock Options (Right to Buy) | $ 94.35 | (6) | 08/12/2021 | Common Stock | 35,000 | 35,000 | D | ||||||||
Stock Options (Right to Buy) | $ 86.25 | (7) | 04/01/2021 | Common Stock | 10,000 | 10,000 | D | ||||||||
Stock Options (Right to buy) | $ 86.25 | (8) | 04/01/2021 | Common Stock | 25,000 | 25,000 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Hippel James 614 MCKINLEY PLACE N.E. MINNEAPOLIS, MN 55413 |
Chief Financial Officer |
/s/ Elizabeth M. Dunshee as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed. | 04/04/2016 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. |
(2) | Includes 1,667 shares of restricted stock units that vest on 3/31/2017 (previously reported on Table II). |
(3) | On April 1, 2014, the reporting person was granted 5,000 restricted stock units, vesting in three equal annual installments beginning on March 31,2015. |
(4) | Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years. |
(5) | 6,250 shares vest on each of 8/7/2016, 8/7/2017, 8/7/2018 and 8/7/2019. |
(6) | 8,750 shares vest on each of 8/12/2015, 8/12/2016, 8/12/2017 and 8/12/2018. |
(7) | Vests in full or in part if certain performance goals are achieved. |
(8) | 6,250 shares vest on each of 4/1/2015, 4/1/2016, 4/1/2017 and 4/1/2018. |